This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignees: Novartis Ag, Qlt Inc.. Active years: 2006-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 3,977 
2 out of 35 
Years Active: 2006-2011
Title: Innovations by Mohammad Azab in Ocular Treatments
Introduction
Mohammad Azab is a notable inventor based in Vancouver, Canada, recognized for his contributions to the field of ophthalmology. He holds two patents that focus on advanced treatments for eye conditions, particularly those related to age-related macular degeneration.
Latest Patents
His latest patents include a method for photodynamic therapy of occult age-related macular degeneration. This invention pertains to the selection and treatment of subjects afflicted with occult choroidal neovascular lesions, utilizing photodynamic therapy (PDT). Another significant patent is an improved method to prevent vision loss, which involves an initial PDT treatment to destroy neovasculature, followed by re-evaluations and necessary retreatments over a six-month period.
Career Highlights
Throughout his career, Mohammad Azab has worked with prominent companies such as QLT Inc. and Novartis AG. His experience in these organizations has contributed to his expertise in developing innovative solutions for ocular health.
Collaborations
He has collaborated with notable professionals in the field, including H Andrew Strong and Troy Albert Reaves, Jr. These partnerships have further enhanced his research and development efforts.
Conclusion
Mohammad Azab's work in ocular treatments showcases his commitment to improving vision health through innovative therapies. His patents reflect significant advancements in the treatment of eye conditions, making a lasting impact in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile